Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $414.08M.
ENTERPRISE VALUE (EV)
$414.08M
Sight Sciences, Inc.
Market Cap
$465.75M
Enterprise Value (EV)
$414.08M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sight Sciences, Inc. (SGHT) | $465.75M | $414.08M |
| Kamada Ltd. (KMDA)vs › | $467.90M | $450.23M |
| Alpha Teknova, Inc. (TKNO)vs › | $469.12M | $490.53M |
| Cerus Corporation (CERS)vs › | $471.57M | $530.39M |
| Arvinas, Inc. (ARVN)vs › | $471.65M | $385.55M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | $255.33M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | $467.77M |
| NRC Health (NRC)vs › | $452.54M | $539.24M |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | $451.82M |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | $515.82M |
Market Cap
$465.75M
Total Debt
$40.30M
Cash
$91.97M
Enterprise Value
$414.08M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
